Biocryst Pharmaceuticals buy Wedbush
Start price
25.02.25
/
50%
€7.80
Target price
25.02.26
€14.28
Performance (%)
-20.43%
Price
20:10
€6.21
Summary
This prediction is currently active. The price of Biocryst Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.43%. This prediction currently runs until 25.02.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -7.413% | -7.413% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Wedbush for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is now covered by analysts at Wedbush. They set an "outperform" rating and a $15.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Wedbush for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.60
30.06.25
30.06.25
€15.36
30.06.26
30.06.26
-18.57%
20:10
20:10
